What Does Wegovy Do? All Doses In Stock UK | Cured
Cheapest What Does Wegovy Do - UK Price From £69.00
Discover what Wegovy does and buy at the cheapest UK price from £69, plus save £20 off with code WEIGHTLOSSNEW.
Takes less than 2 minutes to complete 100% online
Treatment from £69.00
Check if you're eligible
Your BMI
26.8ⓘ Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.
Our Pricing
Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.
2.5mg
1 pen • 4 Weeks
£31.25 / Per Week
Your starting dose – designed to help your body adjust gently to treatment
5mg
1 pen • 4 Weeks
£39.75 / Per Week
First step up – builds on your progress as your body adapts to treatment
7.5mg
1 pen • 4 Weeks
£50.00 / Per Week
Mid-range dose – for continued progression and enhanced results
10mg
1 pen • 4 Weeks
£56.25 / Per Week
Higher strength dose – supports significant weight loss progress
12.5mg
1 pen • 4 Weeks
£62.50 / Per Week
Advanced dose – for patients requiring stronger therapeutic effect
15mg
1 pen • 4 Weeks
£66.75 / Per Week
Maximum dose – the highest available strength for optimal results
0.25mg
1 pen • 4 Weeks
£17.25 / Per Week
Your starting dose – eases your body into treatment with minimal side effects
0.5mg
1 pen • 4 Weeks
£19.75 / Per Week
First step up – continues building tolerance for long-term success
1mg
1 pen • 4 Weeks
£24.75 / Per Week
Mid-range dose – where most patients start seeing meaningful results
1.7mg
1 pen • 4 Weeks
£37.25 / Per Week
Higher strength – supports accelerated weight loss progress
2.4mg
1 pen • 4 Weeks
£44.75 / Per Week
Maximum dose – the highest available strength for optimal weight management
1.5mg
1 pen • 4 Weeks
£20.75 / Per Week
Your starting dose – eases your body into treatment with minimal side effects
4mg
1 pen • 4 Weeks
£27.50 / Per Week
First step up – continues building tolerance for long-term success
9mg
1 pen • 4 Weeks
£35.00 / Per Week
Mid-range dose – where most patients start seeing meaningful results
25mg
1 pen • 4 Weeks
£49.75 / Per Week
Maximum dose – the highest available strength for optimal weight management
What Does Wegovy Do? All Doses In Stock UK Today
Published on: June 03, 2026
Understanding what does Wegovy do UK is essential before starting treatment. Wegovy (semaglutide) is a once-weekly GLP-1 receptor agonist licensed by the MHRA for chronic weight management, clinically proven to reduce body weight by an average of 15% when combined with lifestyle changes [1]. At Cured Pharmacy, all Wegovy doses are in stock today from £79.00, with free clinical consultation and discreet UK delivery.
How Does Wegovy Work for Weight Loss?
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your body produces after eating [1]. This medication works through three primary mechanisms: it slows gastric emptying so you feel fuller for longer, reduces appetite signals in the brain, and improves insulin sensitivity to help regulate blood sugar levels.
In the landmark STEP 1 clinical trial involving 1,961 adults with obesity, participants receiving Wegovy achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. Importantly, 83.5% of participants on Wegovy lost at least 5% of their body weight, whilst 66.1% achieved at least 10% weight reduction — outcomes significantly higher than previous weight management medications [2].
The medication is administered as a subcutaneous injection once weekly, with doses gradually increased over 16-20 weeks to minimise gastrointestinal side effects. This titration schedule allows your body to adjust to the medication whilst optimising therapeutic benefits. All prescription decisions are made by UK-registered prescribers following clinical assessment at Cured Pharmacy.
Wegovy Dosing Schedule and Administration
Wegovy follows a structured dose escalation programme designed to improve tolerability whilst achieving optimal weight loss results. Treatment begins with 0.25mg once weekly for four weeks, then increases monthly through 0.5mg, 1mg, and 1.7mg doses, reaching the maintenance dose of 2.4mg by week 17 [3].
Each pre-filled pen is designed for single use and should be injected subcutaneously into the abdomen, thigh, or upper arm. Patients typically rotate injection sites to reduce the risk of lipodystrophy. The same day each week should be chosen for administration, though the day can be changed if needed, provided at least 48 hours have elapsed since the last dose.
If you miss a dose and the next scheduled dose is more than 48 hours away, take the missed dose as soon as possible. If less than 48 hours remain, skip the missed dose and resume your regular schedule. Never double doses to compensate for missed injections.
What Happens If I Need to Pause Treatment?
If treatment is interrupted for more than two weeks during dose escalation, or more than two weeks at the 2.4mg maintenance dose, your prescriber may recommend restarting at the 0.25mg dose to minimise gastrointestinal side effects. Clinical guidance from your UK healthcare provider is essential before resuming treatment after any extended interruption.
Expected Weight Loss Results with Wegovy
Clinical trial data from the STEP programme provides clear expectations for Wegovy outcomes. In STEP 1, participants lost an average of 15.3kg (approximately 2.4 stone) over 68 weeks when combining Wegovy with reduced-calorie diet and increased physical activity [1]. However, individual results vary significantly based on adherence, baseline weight, metabolic factors, and lifestyle modifications.
Weight loss typically begins within the first month of treatment, with the most significant reductions occurring between weeks 20 and 60. Approximately one-third of patients in clinical trials achieved weight loss of 20% or more — outcomes previously only seen with bariatric surgery [2]. It's important to note these results required consistent medication use alongside dietary changes and regular physical activity.
Your UK prescriber will monitor your progress throughout treatment. NICE guidelines recommend discontinuing Wegovy if patients do not achieve at least 5% weight loss after 6 months at the maintenance dose, as continued use is unlikely to provide meaningful clinical benefit [4]. Regular follow-up consultations ensure treatment remains appropriate and effective for your individual circumstances.
Factors That Influence Wegovy Effectiveness
Response to Wegovy varies based on several factors including baseline BMI, metabolic health, adherence to lifestyle modifications, and genetic factors affecting GLP-1 receptor sensitivity. Patients who combine medication with structured dietary programmes and regular physical activity consistently achieve superior outcomes compared to medication alone. Your clinical team at Cured Pharmacy can provide guidance on optimising lifestyle factors alongside pharmacological treatment.
| Treatment | Active Ingredient | Injection Frequency | Average Weight Loss | Starting Price |
|---|---|---|---|---|
| Wegovy | Semaglutide 2.4mg | Once weekly | 14.9% (68 weeks) | From £69.00 |
| Saxenda | Liraglutide 3mg | Daily | 6.4% (68 weeks) | From £68.00 |
| Mounjaro | Tirzepatide 15mg | Once weekly | Up to 22.5% (72 weeks) | From £124.99 |
Wegovy Side Effects and Safety Profile
The most common side effects of Wegovy are gastrointestinal and typically occur during dose escalation. In clinical trials, nausea affected approximately 44% of participants, diarrhoea 30%, vomiting 24%, and constipation 24% [1]. These effects are generally mild to moderate, occurring most frequently during the first 8-12 weeks, and diminish as your body adjusts to the medication.
Serious but rare side effects include pancreatitis (inflammation of the pancreas), gallbladder problems including gallstones, and hypoglycaemia particularly in patients taking other diabetes medications. Wegovy carries a boxed warning in the US regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [3]. The medication is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
Your UK prescriber will review your complete medical history during consultation to identify any contraindications. Wegovy is not suitable during pregnancy or breastfeeding, and women of childbearing potential should use effective contraception during treatment. If you experience severe abdominal pain, persistent nausea or vomiting, or signs of allergic reaction, seek immediate medical attention and contact your healthcare provider.
Wegovy vs Saxenda: Comparing GLP-1 Weight Loss Treatments
Both Wegovy and Saxenda are GLP-1 receptor agonists licensed in the UK for weight management, but they differ in formulation, dosing frequency, and clinical efficacy. Saxenda contains liraglutide and requires daily subcutaneous injection at a maximum dose of 3mg, whilst Wegovy contains semaglutide and is administered once weekly at a maintenance dose of 2.4mg.
Head-to-head comparison in the STEP 8 trial demonstrated Wegovy's superior efficacy, with participants achieving 15.8% average body weight reduction compared to 6.4% with Saxenda over 68 weeks [5]. The once-weekly administration of Wegovy also offers improved convenience and adherence compared to daily Saxenda injections, though individual patient preferences and tolerability profiles vary.
Both medications require prescription from a UK-registered prescriber following clinical assessment. Your healthcare provider will consider factors including your weight loss goals, previous treatment responses, injection preference, and cost when recommending the most appropriate option. At Cured Pharmacy, our clinical team provides personalised guidance to help you make an informed decision based on your individual circumstances.
Which GLP-1 Treatment Is Right for You?
The choice between Wegovy and Saxenda depends on multiple factors including desired weight loss magnitude, injection frequency preference, side effect tolerance, and budget considerations. Patients seeking maximum weight reduction typically achieve better outcomes with Wegovy, whilst those preferring daily dosing control or who have previously used liraglutide-based treatments may prefer Saxenda. Your UK prescriber will assess your medical history, weight loss goals, and personal preferences during your free online consultation to recommend the most suitable treatment option.
Getting Wegovy from Cured Pharmacy: All Doses in Stock
At Cured Pharmacy, all Wegovy doses from 0.25mg through to 2.4mg maintenance pens are in stock today, priced from £79.00 with transparent upfront pricing shown before your consultation. As a UK-registered pharmacy (GPhC 9012511) under superintendent pharmacist Tarun Kumar (GPhC 2233073), we dispense only genuine UK-licensed medications following clinical assessment by our registered prescribers.
The process begins with a free online consultation taking under 3 minutes, where you'll provide medical history and weight management information for review by a UK-registered prescriber. If clinically appropriate, your prescription is issued and dispensed the same day, with discreet packaging delivered directly to your address. Our clinical team remains available for ongoing support throughout your treatment journey.
Unlike some providers, Cured Pharmacy displays exact pricing before consultation, ensuring complete transparency with no hidden fees or surprise charges. We guarantee the lowest prices in the UK for genuine weight loss medications, with all treatments requiring proper clinical oversight to ensure patient safety. Subject to prescriber approval, you can begin your Wegovy treatment within 24-48 hours of completing your online assessment.
Scientific References
- Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
- Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
- Novo Nordisk. (2023). Wegovy (semaglutide) injection: Prescribing Information. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
- National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE guidance. Retrieved from https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
- Rubino, D., Abrahamsson, N., Davies, M., et al. (2022). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
- Wilding, J. P. H., Batterham, R. L., Davies, M., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553–1564. https://doi.org/10.1111/dom.14725 [accessed 13 August 2026]
- NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
- NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
- NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.
Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary. Weight loss outcomes depend on adherence to treatment, dietary modifications, and physical activity levels.
Trusted by thousands
Real people, real results
Jane L.
"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."
Ann-Marie
"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."
Sacha W.
"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."
Kimberly G.
"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"
Jennifer
"Great really helps cure those nasty habits can't wait for my next mounjaro pen."
How it Works?
Select from our recommended UK-licensed medications.
1Choose your treatment

Select safe UK treatments. Quick answers.
2Answer quick questions

We will deliver direct to you as quickly as tomorrow.
3Get it delivered fast

Start Your Assessment For Weight Loss
Start your journey to better health today.
- Reviewed by UK-based prescribers
- Takes under 3 minutes
- Discreet Packaging
Start Your Journey To Better Health Today
Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.
Start My Assessment Log in to Your AccountFaq
Medically reviewed by
Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)
Reviewed on: June 03, 2026
Last updated on 13 August 2026.
Review History
Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.
Why this page was updated on 13 August 2026
Content checked and updated as part of our periodic review, to ensure accuracy and currentness.
Current version (13 August 2026)
Edited by: The Editorial Team
Medically reviewed by:
Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist
How we source info.
When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.


